Skip to Content

Active Grants

Ongoing Clinical Research Studies

Collaborative Islet Transplant RegistryEmmes Corporation/NIH

  • Jon S. Odorico, MD, Principal Investigator
  • AGR DTD 11/2/06
  • 09/18/06-present

A 56-week randomized, double blind, placebo-controlled, parallel-group, multi-center, multi-national exploratory trial in Islet Cell transplant subjects with type 1 Diabetes Mellitus to evaluate the early use of Liraglutide as an adjunct to standard care regarding the percentage of subjects achieving insulin independence after first transplantation, Phase II.

  • Novonordisk
  • Jon S. Odorico, MD, Principal Investigator
  • 1/1/12-present Copyright © 2016 The Board of Regents of the University of Wisconsin System